US 8980322
Controlled release composition
granted A61KA61K9/209A61P
Quick answer
US patent 8980322 (Controlled release composition) held by Takeda Pharmaceutical Company Limited expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K9/209, A61P, A61P1/04